10/05/2026
More than 40,000 patients in the U.S. may qualify for this potentially life-saving cancer procedure., but only a fraction are receiving it.
For Joseph L. Hayhurst, MD of Hayhurst Medical Technologies Inc., that gap became impossible to ignore.
His work started with a medical device designed to improve CRS-HIPEC treatment (cytoreductive surgery and hyperthermic intraperitoneal chemotherapy). But as he dug deeper, he discovered another problem: potentially eligible patients weren’t making it to the specialists who perform the procedure.
Now, Hayhurst Medical Technologies is developing software to identify those patients using data already buried in hospital reports and route them to the appropriate specialists.
“This is their last resort.”
Joseph shared the problem, the opportunity, and what he’s building with the 1 Million Cups Kansas City community in September.
Join us every Wednesday morning for presentations on some of the amazing technologies, businesses, and services local entrepreneurs and founders are building in the KC area and beyond!